Bradley Greenhaw, MD
Dermatology · Tupelo, MSNPI 1215249131
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.5% of the total across 1,021 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 35 manufacturers reported payments, led by AbbVie at 25.9% of the total.
Across 1,021 payments — averaging $16.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$4K
- Novartis$2K
- Johnson & Johnson$2K
- Sun Pharmaceutical Industries Inc.$2K
- Regeneron Healthcare Solutions, Inc.$919
- UCB, Inc.$909
- plus $5K from 29 others
What the payments were for
- Food & beverage$16,53997%
- Education$4323%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 267 | $4,394 |
| Novartis | 153 | $1,951 |
| Johnson & Johnson | 125 | $1,722 |
| Sun Pharmaceutical Industries Inc. | 78 | $1,634 |
| Regeneron Healthcare Solutions, Inc. | 43 | $919 |
| UCB, Inc. | 50 | $909 |
| Lilly USA, LLC | 48 | $871 |
| Sanofi | 36 | $714 |
| LEO Pharma Inc. | 40 | $686 |
| E.r. Squibb & Sons, L.L.C. | 37 | $665 |
| Pfizer | 24 | $379 |
| Amgen | 19 | $371 |
| Organon | 12 | $205 |
| Organogenesis Inc. | 9 | $193 |
| Kerecis Limited | 8 | $164 |
| Incyte Corporation | 15 | $160 |
| Genentech USA, Inc. | 10 | $151 |
| Mallinckrodt Hospital Products Inc. | 6 | $122 |
| Boehringer Ingelheim | 7 | $122 |
| Galderma Laboratories, L.p. | 7 | $106 |
| Sandoz | 2 | $95 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 4 | $58 |
| Dermavant Sciences, Inc. | 3 | $48 |
| Mayne Pharma Commercial LLC | 2 | $47 |
| Dermira, Inc. | 2 | $40 |
| Biofrontera Inc. | 2 | $40 |
| Fresenius Kabi USA, LLC | 2 | $40 |
| DUSA Pharmaceuticals, Inc. | 2 | $32 |
| Melinta Therapeutics, LLC | 2 | $31 |
| Smith+Nephew | 1 | $22 |
| Misonix Inc | 1 | $21 |
| Nabriva Therapeutics, PLC | 1 | $18 |
| Arcutis Biotherapeutics, Inc. | 1 | $16 |
| Merck | 1 | $12 |
| Prugen, Inc. Pharmaceuticals | 1 | $11 |
How this compares
$16,971 in reported general payments places this provider in the 80th percentile of 78 dermatology providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 19 | $129,228 |
| Fluocinonide | 18 | $728 |
| Doxycycline Hyclate | 106 | $706 |
| Metronidazole | 20 | $666 |
| Clobetasol Propionate | 14 | $557 |
| Triamcinolone Acetonide | 46 | $479 |
| Cephalexin | 142 | $317 |
| Acyclovir | 14 | $197 |
| Fluticasone Propionate | 12 | $186 |
| Hydrocortisone | 40 | $158 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 66 | $143 |
| Clindamycin Hcl | 11 | $17 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Tupelo
- Jeffrey HouinTupelo$27K
- James ParkerTupelo$2K
- John BurkTupelo$2K
- Jeremy JacksonJackson$450K
- Lindsey ZubritskyOcean Springs$349K
- Maureen OffiahHattiesburg$275K
- Lyndsay ShippOxford$246K
- Steven ShapiroHattiesburg$165K
- Joseph TerracinaGreenville$86K
- Thy HuynhJackson$51K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.